A Dose-Ranging Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
Latest Information Update: 13 Oct 2022
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Subcutaneous fat disorders
- Focus Therapeutic Use
Most Recent Events
- 10 Oct 2022 Planned End Date changed from 1 Jun 2022 to 1 Nov 2022.
- 10 Oct 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Nov 2022.
- 10 Oct 2022 Status changed from recruiting to active, no longer recruiting.